Skip to main content
logo
Biofrontera logo
Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.9700
+0.0512 (5.57%)
At close: Oct 9, 2026, 4:00 PM EDT
0.9429
-0.0271 (-2.79%)
After-hours: Oct 9, 2026, 6:06 PM EDT

Biofrontera Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
46.1841.7137.3234.0728.6724.1
Revenue Growth
17.83%11.75%9.54%18.82%18.98%27.86%
Gross Profit
36.630.7418.7116.6313.4911.36
Operating Income
-6.17-11.35-17.21-21.35-21.51-14.6
Net Income
-6.37-10.54-17.76-20.13-0.64-37.71
Earnings Per Share
-0.54-1.04-3.22-13.02-0.61-85.63
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.676.45.911.4227.7624.55
Total Debt
7.56.164.925.41.35-
Net Cash (Debt)
-2.840.240.99-3.9826.4124.55
Net Cash Growth
--75.76%--7.60%203.78%
Net Cash Per Share
-0.240.020.18-2.5724.9955.73

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.93-13.36-10.27-24.9-16.2-26.72
Capital Expenditures
-0-0-0.01-0.01-0.04-0.01
Free Cash Flow
-7.93-13.36-10.28-24.9-16.24-26.73
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
79.25%73.71%50.14%48.80%47.04%47.13%
Operating Margin
-13.36%-27.21%-46.11%-62.67%-75.02%-60.59%
Pretax Margin
-13.72%-25.20%-47.53%-59.04%-2.12%-156.25%
Profit Margin
-13.79%-25.26%-47.58%-59.09%-2.23%-156.49%
FCF Margin
-17.17%-32.04%-27.54%-73.08%-56.63%-110.90%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.310.160.230.120.855.34